Publications by authors named "Hilel Alapi"

Claim this Profile
I
Intake of Proton Pump Inhibitors Is Associated with a Shorter Time to First Treatment in Early-Stage Chronic Lymphocytic Leukemia.
Tamar Tadmor, Tamar Tadmor, Guy Melamed, Hilel Alapi, Sivan Gazit

Acta Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic lymphocytic leukemia and associated chronic lung diseases.
Tamar Tadmor, Emilia Hardak, Guy Melamed, Hilel Alapi, Lior Rokach

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple A Plus (AAA ) Survival Prediction Model for Essential Thrombocythemia: Analysis Involving 7308 Patients.
Ayalew Tefferi, Giuseppe G Loscocco, Lior Rokach, Tamar Tadmor, Priyansh Faldu, Hilel Alapi

Am J Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intake of benzodiazepines in treatment naïve chronic lymphocytic leukemia patients is associate with a shorter time to first treatment.
Tamar Tadmor, Gal Lavie, Guy Melamed, Hilel Alapi, Lior Rokach

Leuk Lymphoma· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLLAF SCORE-A New Risk Score for Predicting Atrial Fibrillation in Treatment-Naive CLL Patients Initiating First- and Second-Generation BTK Inhibitor Therapy.
Tamar Tadmor, Guy Melamed, Hilel Alapi, Lior Rokach

Eur J Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D supplement for patients with early-stage chronic lymphocytic leukemia is associated with a longer time to first treatment.
Tamar Tadmor, Guy Melamed, Hilel Alapi, Sivan Gazit, Tal Patalon

Blood Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Survival of Patients With Chronic Lymphocytic Leukemia Between 1998-2022, Including the Era of Target Therapies With BCL2 and BTK Inhibitors.
Tamar Tadmor, Guy Melamed, Hilel Alapi, Sivam Gazit, Tal Patalon

Anticancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The course of patients with hairy cell leukemia during the omicron surge of the Covid-19 pandemic.
Tamar Tadmor, Guy Melamed, Tal Patalon, Hilel Alapi, Lior Rokach

Hematol Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effectiveness of Bivalent mRNA Omicron Containing Booster Vaccines Among Patients With Hematological Neoplasms.
Tamar Tadmor, Guy Melamed, Hilel Alapi, Tal Patalon, Lior Rokach

Anticancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of nirmatrelvir plus ritonavir treatment for patients with chronic lymphocytic leukemia during the Omicron surge.
Tamar Tadmor, Hilel Alapi, Lior Rokach

Blood· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir.
Tamar Tadmor, Guy Melamed, Tal Patalon, Hilel Alapi, Lior Rokach

Leuk Lymphoma· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis